ARWR - Arrowhead Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARWR is currently covered by 13 analysts with an average price target of $40.3. This is a potential upside of $20.42 (102.72%) from yesterday's end of day stock price of $19.88.

Arrowhead Pharmaceuticals's activity chart (see below) currently has 180 price targets and 177 ratings on display. The stock rating distribution of ARWR is 90.74% BUY and 9.26% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.97% with an average time for these price targets to be met of 252.16 days.

Highest price target for ARWR is $80, Lowest price target is $27, average price target is $40.3.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 23-Jan-2025. First documented stock forecast 05-Mar-2014.

Currently out of the existing stock ratings of ARWR, 49 are a BUY (90.74%), 5 are a HOLD (9.26%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$80

$60.12 (302.41%)

$80

9 days ago
(23-Jan-2025)

0/22 (0%)

$58.47 (271.57%)

Buy

$60

$40.12 (201.81%)

$60

1 months 20 days ago
(12-Dec-2024)

4/18 (22.22%)

$37.86 (171.00%)

193

Buy

$45

$25.12 (126.36%)

$62

2 months 5 days ago
(27-Nov-2024)

22/36 (61.11%)

$21.03 (87.73%)

154

Buy

$42

$22.12 (111.27%)

$50

4 months 6 days ago
(26-Sep-2024)

2/9 (22.22%)

$22.38 (114.07%)

100

Buy

$55

$35.12 (176.66%)

$55

5 months 20 days ago
(12-Aug-2024)

8/15 (53.33%)

$32.06 (139.76%)

135

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?

On average it took 252.16 days on average for the stock forecasts to be realized with a an average price target met ratio 66.97

Which analyst has the current highest performing score on ARWR (Arrowhead Pharmaceuticals) with a proven track record?

LUCA ISSI

Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?

Luca Issi works at RBC and has 8 price targets and 5 ratings on ARWR

Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?

Esther Rajavelu with highest potential upside - $75.13

Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?

Alethia Young with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?